血清血红蛋白浓度与早期糖尿病肾病肾功能下降风险:全国性活检队列研究
该研究基于全国性活检证实的糖尿病肾病患者数据,纳入246例肾活检时eGFR≥60 mL/min/1.73 m2的患者,探讨血清血红蛋白浓度与肾脏病理严重程度及DKD进展风险的关联。中位随访4.1年,95例发生DKD进展;血清血红蛋白与间质纤维化严重程度负相关(ρ=-0.52,P<0.001),且独立预测DKD进展,加入已知风险因素可改善预后价值(全局卡方统计量从55.1升至60.8,P<0.001)。
要点
- 血清血红蛋白与肾脏病理特征负相关,尤其与间质纤维化严重程度相关。
- 在早期DKD患者中,较低血清血红蛋白水平独立增加DKD进展风险。
- 将血清血红蛋白加入已知风险因素可改善DKD进展的预后预测价值。
核心结论
- 血清血红蛋白浓度反映早期肾纤维化,可用于预测早期糖尿病肾病患者的DKD进展。
研究设计与样本
- 基于全国代表性活检证实的DKD患者数据,纳入246例肾活检时eGFR≥60 mL/min/1.73 m2的患者。
- 中位年龄56(45-63)岁,男性占62.6%,血红蛋白13.3(12.0-14.5)g/dL,eGFR 76.2(66.6-88.6)mL/min/1.73 m2,尿白蛋白肌酐比534(100-1480)mg/g Crea。
- 血清血红蛋白按四分位数分组:≤12、12.1-13.3、13.4-14.5和≥14.6 g/dL。
- 采用多变量Cox回归模型估计DKD进展风险(新发终末期肾病、eGFR下降50%或血清肌酐翻倍)。
主要发现
- 血清血红蛋白水平与所有肾脏病理特征负相关,尤其与间质纤维化严重程度相关(ρ=-0.52;P<0.001)。
- 中位随访4.1年,95例发生DKD进展。
- 调整已知风险因素后,第一、第二和第三四分位(第四四分位为参照)的风险比分别为2.74(95%CI 1.26-5.97)、2.33(95%CI 1.07-5.75)和1.46(95%CI 0.71-3.64)。
- 将血清血红蛋白加入已知风险因素后,DKD进展的预后价值改善(全局卡方统计量从55.1增至60.8;P<0.001)。
临床怎么用
- 在早期DKD(eGFR≥60 mL/min/1.73 m2)患者中,可关注血清血红蛋白浓度以辅助风险分层。
- 血清血红蛋白较低可能提示更严重的肾间质纤维化,需加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prognosticating disease progression in patients with diabetic kidney disease (DKD) is challenging, especially in the early stages of kidney disease. Anemia can occur in the early stages of kidney disease in diabetes. We therefore postulated that serum hemoglobin (Hb) concentration, as a reflection of incipient renal tubulointerstitial impairment, can be used as a marker to predict DKD progression. METHODS: Drawing on nationally representative data of patients with biopsy-proven DKD, 246 patients who had an estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2 at renal biopsy were identified: age 56 (45-63) years; 62.6% men; Hb 13.3 (12.0-14.5) g/dL; eGFR 76.2 (66.6-88.6) mL/min/1.73 m2; urine albumin-to-creatinine ratio 534 (100-1480) mg/g Crea. Serum Hb concentration was divided into quartiles: ≤12, 12.1-13.3, 13.4-14.5 and ≥14.6 g/dL. The association between serum Hb concentration and the severity of renal pathological lesions was explored. A multivariable Cox regression model was used to estimate the risk of DKD progression (new onset of end-stage kidney disease, 50% reduction of eGFR or doubling of serum creatinine). The incremental prognostic value of DKD progression by adding serum Hb concentration to the known risk factors of DKD was assessed. RESULTS: Serum Hb levels negatively correlated with all renal pathological features, especially with the severity of interstitial fibrosis (ρ = -0.52; P < 0.001). During a median follow-up of 4.1 years, 95 developed DKD progression. Adjusting for known risk factors of DKD progression, the hazard ratio in the first, second and third quartile (the fourth quartile was reference) were 2.74 [95% confidence interval (CI) 1.26-5.97], 2.33 (95% CI 1.07-5.75) and 1.46 (95% CI 0.71-3.64), respectively. Addition of the serum Hb concentration to the known risk factors of DKD progression improved the prognostic value of DKD progression (the global Chi-statistics increased from 55.1 to 60.8; P < 0.001). CONCLUSIONS: Serum Hb concentration, which reflects incipient renal fibrosis, can be useful for predicting DKD progression in the early stages of kidney disease.
引用
- Yamanouchi M, Furuichi K, Shimizu M, et al. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study. Nephrol Dial Transplant. 2022. PMID: 34028524. doi:10.1093/ndt/gfab185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。